{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T05:25:47Z","timestamp":1793510747251,"version":"4.5.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Programa Presupuestal P016, Anexo 13 del Decreto del Presupuesto de Egresos de la Federaci\u00f3n."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-04313-9","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T01:53:50Z","timestamp":1756691630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Differential effects of switching to integrase strand transfer inhibitors on the gut microbiota and markers of HIV disease progression"],"prefix":"10.1186","volume":"25","author":[{"given":"Sandra M.","family":"Pinto-Cardoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Aguilar-Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"L\u00f3pez-Filloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monserrat","family":"Ch\u00e1vez-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Murakami-Osawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Brice\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Romero-Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Rodr\u00edguez-Moguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Salgado Montes de Oca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"\u00c1vila-R\u00edos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"MESCAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Bethel","family":"Peralta-Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"C\u00e1rdenas Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Ram\u00edrez Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna Hania","family":"Rodrigu\u00e9z Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flor","family":"Cano Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Lorena","family":"Jim\u00e9nez S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma Emilia","family":"Mirafuentes Ram\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ram\u00f3n Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Garrido-Rodrigu\u00e9z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"4313_CR1","unstructured":"Sida CN. para la P y C del V y el. gob.mx. [cited 2024 Apr 22]. Gu\u00eda de Manejo Antirretroviral de las Personas con VIH - M\u00e9xico 2021. Available from: http:\/\/www.gob.mx\/censida\/documentos\/guia-de-manejo-antirretroviral-de-las-personas-con-vih-mexico-2021-297710"},{"issue":"3","key":"4313_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/hiv.13386","volume":"24","author":"A Avihingsanon","year":"2023","unstructured":"Avihingsanon A, Chetchotisakd P, Kiertiburanakul S, Ratanasuwan W, Siripassorn K, Supparatpinyo K, et al. Efficacy and safety of switching to bictegravir, emtricitabine, and Tenofovir Alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials. HIV Med. 2023;24(3):290\u2013300.","journal-title":"HIV Med"},{"issue":"Suppl 5","key":"4313_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/hiv.12440","volume":"17","author":"F Raffi","year":"2016","unstructured":"Raffi F, Esser S, Nunnari G, P\u00e9rez-Valero I, Waters L. Switching regimens in virologically suppressed HIV-1-infected patients: evidence base and rationale for integrase strand transfer inhibitor (INSTI)-containing regimens. HIV Med. 2016;17(Suppl 5):3\u201316.","journal-title":"HIV Med"},{"key":"4313_CR4","doi-asserted-by":"crossref","unstructured":"Norwood J, Turner M, Bofill C, Rebeiro P, Shepherd B, Bebawy S et al. Weight Gain in Persons with HIV Switched from Efavirenz-based to Integrase Strand Transfer Inhibitor-based Regimens. J Acquir Immune Defic Syndr. 1999. 2017;76(5):527\u201331.","DOI":"10.1097\/QAI.0000000000001525"},{"issue":"3","key":"4313_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/COH.0000000000000680","volume":"16","author":"JE Lake","year":"2021","unstructured":"Lake JE, Trevillyan J. Impact of integrase inhibitors and Tenofovir Alafenamide on weight gain in people with HIV. Curr Opin HIV AIDS. 2021;16(3):148\u201351.","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"4313_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1089\/aid.2015.0147","volume":"32","author":"JR Koethe","year":"2016","unstructured":"Koethe JR, Jenkins CA, Lau B, Shepherd BE, Justice AC, Tate JP, et al. Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the united States and Canada. AIDS Res Hum Retroviruses. 2016;32(1):50\u20138.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"11","key":"4313_CR7","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1097\/QAD.0000000000003281","volume":"36","author":"S Savinelli","year":"2022","unstructured":"Savinelli S, Wrigley Kelly NE, Feeney ER, O\u2019Shea DB, Hogan AE, Overton ET, et al. Obesity in HIV infection: host-pathogen interaction. AIDS Lond Engl. 2022;36(11):1477\u201391.","journal-title":"AIDS Lond Engl"},{"issue":"1","key":"4313_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2055-6640(20)30277-6","volume":"5","author":"A Hill","year":"2019","unstructured":"Hill A, Waters L, Pozniak A. Are new antiretroviral treatments increasing the risks of clinical obesity? J Virus Erad. 2019;5(1):41\u20133.","journal-title":"J Virus Erad"},{"issue":"10","key":"4313_CR9","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1080\/09540121.2023.2185195","volume":"35","author":"J Ken-Opurum","year":"2023","unstructured":"Ken-Opurum J, Prajapati G, Matos JE, Goswami S, Kumar P. Body mass index and quality of life in people living with HIV. AIDS Care. 2023;35(10):1542\u201354.","journal-title":"AIDS Care"},{"issue":"1","key":"4313_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/QCO.0000000000000616","volume":"33","author":"AR Eckard","year":"2020","unstructured":"Eckard AR, McComsey GA. Weight gain and integrase inhibitors. Curr Opin Infect Dis. 2020;33(1):10\u20139.","journal-title":"Curr Opin Infect Dis"},{"issue":"12","key":"4313_CR11","doi-asserted-by":"publisher","first-page":"ofab542","DOI":"10.1093\/ofid\/ofab542","volume":"8","author":"BR Wood","year":"2021","unstructured":"Wood BR, Huhn GD. Excess weight gain with integrase inhibitors and Tenofovir alafenamide: what is the mechanism and does it matter?? Open Forum Infect Dis. 2021;8(12):ofab542.","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"4313_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1089\/aid.2022.0130","volume":"39","author":"E P\u00e9rez-Barrag\u00e1n","year":"2023","unstructured":"P\u00e9rez-Barrag\u00e1n E, Guevara-Maldonado MF, Mancilla-Galindo J, Kammar-Garc\u00eda A, Ortiz-Hern\u00e1ndez A, Mata-Mar\u00edn JA, et al. Weight gain after 12 months of switching to bictegravir\/emtricitabine\/tenofovir Alafenamide in virologically suppressed HIV patients. AIDS Res Hum Retroviruses. 2023;39(10):511\u20137.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"4313_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/09564624231196605","volume":"35","author":"JA Mata Mar\u00edn","year":"2024","unstructured":"Mata Mar\u00edn JA, Velasco-Penagos JC, Mauss S, Rodriguez-Evaristo MS, P\u00e9rez-Barrag\u00e1n E, Villa-Platas J, et al. Weight gain and metabolic disturbances in people living with HIV who start antiretroviral therapy with, or switch to, bictegravir\/emtricitabine\/tenofovir Alafenamide after 48 weeks of treatment: A real-world prospective study. Int J STD AIDS. 2024;35(1):33\u20138.","journal-title":"Int J STD AIDS"},{"issue":"7","key":"4313_CR14","doi-asserted-by":"publisher","first-page":"e2153","DOI":"10.1093\/cid\/ciaa1219","volume":"73","author":"MA Leonard","year":"2021","unstructured":"Leonard MA, Cindi Z, Bradford Y, Bourgi K, Koethe J, Turner M, et al. Efavirenz pharmacogenetics and weight gain following switch to integrase Inhibitor-Containing regimens. Clin Infect Dis Off Publ Infect Dis Soc Am. 2021;73(7):e2153\u201363.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"4","key":"4313_CR15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/infdis\/jis720","volume":"207","author":"GA McComsey","year":"2013","unstructured":"McComsey GA, Daar ES, O\u2019Riordan M, Collier AC, Kosmiski L, Santana JL, et al. Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or Tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS clinical trials group study A5224s, substudy of A5202. J Infect Dis. 2013;207(4):604\u201311.","journal-title":"J Infect Dis"},{"issue":"3","key":"4313_CR16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.idc.2024.04.005","volume":"38","author":"SS Bailin","year":"2024","unstructured":"Bailin SS, Koethe JR. Weight gain and antiretroviral therapy. Infect Dis Clin North Am. 2024;38(3):499\u2013515.","journal-title":"Infect Dis Clin North Am"},{"issue":"10","key":"4313_CR17","doi-asserted-by":"publisher","first-page":"e549","DOI":"10.1093\/cid\/ciaa259","volume":"71","author":"J Gorwood","year":"2020","unstructured":"Gorwood J, Bourgeois C, Pourcher V, Pourcher G, Charlotte F, Mantecon M, et al. The integrase inhibitors dolutegravir and raltegravir exert proadipogenic and profibrotic effects and induce insulin resistance in human\/simian adipose tissue and human adipocytes. Clin Infect Dis Off Publ Infect Dis Soc Am. 2020;71(10):e549\u201360.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"4313_CR18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.antiviral.2018.04.002","volume":"154","author":"J Couturier","year":"2018","unstructured":"Couturier J, Winchester LC, Suliburk JW, Wilkerson GK, Podany AT, Agarwal N, et al. Adipocytes impair efficacy of antiretroviral therapy. Antiviral Res. 2018;154:140\u20138.","journal-title":"Antiviral Res"},{"issue":"6","key":"4313_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/25787489.2020.1848131","volume":"21","author":"P Debroy","year":"2020","unstructured":"Debroy P, Feng H, Miao H, Milic J, Ligabue G, Draisci S, et al. Changes in central adipose tissue after switching to integrase inhibitors. HIV Res Clin Pract. 2020;21(6):168\u201373.","journal-title":"HIV Res Clin Pract"},{"key":"4313_CR20","doi-asserted-by":"publisher","first-page":"120948","DOI":"10.1016\/j.lfs.2022.120948","volume":"308","author":"P Domingo","year":"2022","unstructured":"Domingo P, Quesada-L\u00f3pez T, Villarroya J, Cair\u00f3 M, Gutierrez MDM, Mateo MG, et al. Differential effects of dolutegravir, bictegravir and raltegravir in adipokines and inflammation markers on human adipocytes. Life Sci. 2022;308:120948.","journal-title":"Life Sci"},{"issue":"4","key":"4313_CR21","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s40121-022-00654-4","volume":"11","author":"P Villoslada-Blanco","year":"2022","unstructured":"Villoslada-Blanco P, P\u00e9rez-Matute P, \u00cd\u00f1iguez M, Recio-Fern\u00e1ndez E, Blanco-Navarrete P, Metola L, et al. Integrase inhibitors partially restore bacterial translocation, inflammation and gut permeability induced by HIV infection: impact on gut microbiota. Infect Dis Ther. 2022;11(4):1541\u201357.","journal-title":"Infect Dis Ther"},{"issue":"9","key":"4313_CR22","doi-asserted-by":"publisher","first-page":"4830","DOI":"10.3390\/ijms25094830","volume":"25","author":"TA Baltazar-D\u00edaz","year":"2024","unstructured":"Baltazar-D\u00edaz TA, Andrade-Villanueva JF, S\u00e1nchez-\u00c1lvarez P, Amador-Lara F, Holgu\u00edn-Aguirre T, S\u00e1nchez-Reyes K, et al. A Two-Faced gut microbiome: butyrogenic and Proinflammatory bacteria predominate in the intestinal milieu of people living with HIV from Western Mexico. Int J Mol Sci. 2024;25(9):4830.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4313_CR23","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3390\/microorganisms11040951","volume":"11","author":"TA Baltazar-D\u00edaz","year":"2023","unstructured":"Baltazar-D\u00edaz TA, Amador-Lara F, Andrade-Villanueva JF, Gonz\u00e1lez-Hern\u00e1ndez LA, Cabrera-Silva RI, S\u00e1nchez-Reyes K, et al. Gut bacterial communities in HIV-Infected individuals with metabolic syndrome: effects of the therapy with integrase strand transfer Inhibitor-Based and protease Inhibitor-Based regimens. Microorganisms. 2023;11(4):951.","journal-title":"Microorganisms"},{"key":"4313_CR24","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41598-020-80247-8","volume":"11","author":"M Imahashi","year":"2021","unstructured":"Imahashi M, Ode H, Kobayashi A, Nemoto M, Matsuda M, Hashiba C, et al. Impact of long-term antiretroviral therapy on gut and oral microbiotas in HIV-1-infected patients. Sci Rep. 2021;11:960.","journal-title":"Sci Rep"},{"key":"4313_CR25","doi-asserted-by":"publisher","first-page":"43741","DOI":"10.1038\/srep43741","volume":"7","author":"S Pinto-Cardoso","year":"2017","unstructured":"Pinto-Cardoso S, Lozupone C, Brice\u00f1o O, Alva-Hern\u00e1ndez S, T\u00e9llez N, Adriana A, et al. Fecal bacterial communities in treated HIV infected individuals on two antiretroviral regimens. Sci Rep. 2017;7:43741.","journal-title":"Sci Rep"},{"issue":"4","key":"4313_CR26","doi-asserted-by":"publisher","first-page":"562","DOI":"10.4161\/gmic.32132","volume":"5","author":"CA Lozupone","year":"2014","unstructured":"Lozupone CA, Rhodes ME, Neff CP, Fontenot AP, Campbell TB, Palmer BE. HIV-induced alteration in gut microbiota: driving factors, consequences, and effects of antiretroviral therapy. Gut Microbes. 2014;5(4):562\u201370.","journal-title":"Gut Microbes"},{"key":"4313_CR27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40168-023-01718-4","volume":"12","author":"AS Burkhart Colorado","year":"2024","unstructured":"Burkhart Colorado AS, Lazzaro A, Neff CP, Nusbacher N, Boyd K, Fiorillo S, et al. Differential effects of antiretroviral treatment on immunity and gut Microbiome composition in people living with HIV in rural versus urban Zimbabwe. Microbiome. 2024;12:18.","journal-title":"Microbiome"},{"issue":"1","key":"4313_CR28","doi-asserted-by":"publisher","first-page":"17820","DOI":"10.1038\/s41598-024-68479-4","volume":"14","author":"A Narayanan","year":"2024","unstructured":"Narayanan A, Kieri O, Vesterbacka J, Manoharan L, Chen P, Ghorbani M, et al. Exploring the interplay between antiretroviral therapy and the gut-oral Microbiome axis in people living with HIV. Sci Rep. 2024;14(1):17820.","journal-title":"Sci Rep"},{"issue":"1","key":"4313_CR29","doi-asserted-by":"publisher","first-page":"14327","DOI":"10.1038\/s41598-023-41434-5","volume":"13","author":"P Villoslada-Blanco","year":"2023","unstructured":"Villoslada-Blanco P, P\u00e9rez-Matute P, Recio-Fern\u00e1ndez E, \u00cd\u00f1iguez M, Blanco-Navarrete P, Metola L, et al. Beyond the effects of HIV infection and integrase inhibitors-based therapies on oral bacteriome. Sci Rep. 2023;13(1):14327.","journal-title":"Sci Rep"},{"issue":"1","key":"4313_CR30","doi-asserted-by":"publisher","first-page":"21526","DOI":"10.7448\/IAS.20.1.21526","volume":"20","author":"MJ Villanueva-Mill\u00e1n","year":"2017","unstructured":"Villanueva-Mill\u00e1n MJ, P\u00e9rez-Matute P, Recio-Fern\u00e1ndez E, Lezana Rosales JM, Oteo JA. Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients. J Int AIDS Soc. 2017;20(1):21526.","journal-title":"J Int AIDS Soc"},{"issue":"10","key":"4313_CR31","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41575-022-00631-9","volume":"19","author":"PD Cani","year":"2022","unstructured":"Cani PD, Depommier C, Derrien M, Everard A, de Vos WM. Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat Rev Gastroenterol Hepatol. 2022;19(10):625\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4313_CR32","doi-asserted-by":"publisher","first-page":"639291","DOI":"10.3389\/fimmu.2021.639291","volume":"12","author":"G Ancona","year":"2021","unstructured":"Ancona G, Merlini E, Tincati C, Barassi A, Calcagno A, Augello M, et al. Long-Term suppressive cART is not sufficient to restore intestinal permeability and gut microbiota compositional changes. Front Immunol. 2021;12:639291.","journal-title":"Front Immunol"},{"issue":"1","key":"4313_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/17474124.2019.1543023","volume":"13","author":"T Singer-Englar","year":"2019","unstructured":"Singer-Englar T, Barlow G, Mathur R. Obesity, diabetes, and the gut microbiome: an updated review. Expert Rev Gastroenterol Hepatol. 2019;13(1):3\u201315.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"2","key":"4313_CR34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3746\/pnf.2020.25.2.113","volume":"25","author":"A Aoun","year":"2020","unstructured":"Aoun A, Darwish F, Hamod N. The influence of the gut Microbiome on obesity in adults and the role of probiotics, prebiotics, and synbiotics for weight loss. Prev Nutr Food Sci. 2020;25(2):113\u201323.","journal-title":"Prev Nutr Food Sci"},{"issue":"4","key":"4313_CR35","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/cid\/ciae191","volume":"79","author":"DA Wohl","year":"2024","unstructured":"Wohl DA, Koethe JR, Sax PE, McComsey GA, Kuritzkes DR, Moyle G, et al. Antiretrovirals and weight change: weighing the evidence. Clin Infect Dis Off Publ Infect Dis Soc Am. 2024;79(4):999\u20131005.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"1","key":"4313_CR36","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s40168-024-01925-7","volume":"12","author":"C Boukadida","year":"2024","unstructured":"Boukadida C, Peralta-Prado A, Ch\u00e1vez-Torres M, Romero-Mora K, Rincon-Rubio A, \u00c1vila-R\u00edos S, et al. Alterations of the gut Microbiome in HIV infection highlight human anelloviruses as potential predictors of immune recovery. Microbiome. 2024;12(1):204.","journal-title":"Microbiome"},{"key":"4313_CR37","doi-asserted-by":"publisher","first-page":"7652408","DOI":"10.1155\/2022\/7652408","volume":"2022","author":"LA Tucker","year":"2022","unstructured":"Tucker LA, Parker K. 10-Year weight gain in 13,802 US adults: the role of age, sex, and race. J Obes. 2022;2022:7652408.","journal-title":"J Obes"},{"issue":"9","key":"4313_CR38","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3109\/00365529709011203","volume":"32","author":"SJ Lewis","year":"1997","unstructured":"Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32(9):920\u20134.","journal-title":"Scand J Gastroenterol"},{"issue":"6285","key":"4313_CR39","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1126\/science.aad3503","volume":"352","author":"G Falony","year":"2016","unstructured":"Falony G, Joossens M, Vieira-Silva S, Wang J, Darzi Y, Faust K, et al. Population-level analysis of gut Microbiome variation. Science. 2016;352(6285):560\u20134.","journal-title":"Science"},{"issue":"3","key":"4313_CR40","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/gutjnl-2015-310328","volume":"65","author":"EF Tigchelaar","year":"2016","unstructured":"Tigchelaar EF, Bonder MJ, Jankipersadsing SA, Fu J, Wijmenga C, Zhernakova A. Gut microbiota composition associated with stool consistency. Gut. 2016;65(3):540\u20132.","journal-title":"Gut"},{"issue":"9","key":"4313_CR41","doi-asserted-by":"publisher","first-page":"16093","DOI":"10.1038\/nmicrobiol.2016.93","volume":"1","author":"HM Roager","year":"2016","unstructured":"Roager HM, Hansen LBS, Bahl MI, Frandsen HL, Carvalho V, G\u00f8bel RJ, et al. Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut. Nat Microbiol. 2016;1(9):16093.","journal-title":"Nat Microbiol"},{"issue":"7","key":"4313_CR42","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0009-9120(03)00096-1","volume":"36","author":"MMAL Pelsers","year":"2003","unstructured":"Pelsers MMAL, Namiot Z, Kisielewski W, Namiot A, Januszkiewicz M, Hermens WT, et al. Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem. 2003;36(7):529\u201335.","journal-title":"Clin Biochem"},{"key":"4313_CR43","doi-asserted-by":"publisher","first-page":"1244473","DOI":"10.3389\/fimmu.2023.1244473","volume":"14","author":"C Rosel-Pech","year":"2023","unstructured":"Rosel-Pech C, Pinto-Cardoso S, Ch\u00e1vez-Torres M, Montufar N, Osuna-Padilla I, \u00c1vila-R\u00edos S, et al. Distinct fecal microbial signatures are linked to sex and chronic immune activation in pediatric HIV infection. Front Immunol. 2023;14:1244473.","journal-title":"Front Immunol"},{"issue":"1","key":"4313_CR44","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/nar\/gks808","volume":"41","author":"A Klindworth","year":"2013","unstructured":"Klindworth A, Pruesse E, Schweer T, Peplies J, Quast C, Horn M, et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2013;41(1):e1.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"4313_CR45","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, et al. Reproducible, interactive, scalable and extensible Microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852\u20137.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"4313_CR46","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1128\/AEM.03006-05","volume":"72","author":"TZ DeSantis","year":"2006","unstructured":"DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, et al. Greengenes, a Chimera-Checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006;72(7):5069\u201372.","journal-title":"Appl Environ Microbiol"},{"issue":"7","key":"4313_CR47","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: High-resolution sample inference from illumina amplicon data. Nat Methods. 2016;13(7):581\u20133.","journal-title":"Nat Methods"},{"issue":"Database issue","key":"4313_CR48","first-page":"D590","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41(Database issue):D590\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4313_CR49","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40168-018-0470-z","volume":"6","author":"NA Bokulich","year":"2018","unstructured":"Bokulich NA, Kaehler BD, Rideout JR, Dillon M, Bolyen E, Knight R, et al. Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2\u2019s q2-feature-classifier plugin. Microbiome. 2018;6(1):90.","journal-title":"Microbiome"},{"issue":"1","key":"4313_CR50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41592-023-02092-7","volume":"21","author":"H Lin","year":"2024","unstructured":"Lin H, Peddada SD. Multigroup analysis of compositions of microbiomes with covariate adjustments and repeated measures. Nat Methods. 2024;21(1):83\u201391.","journal-title":"Nat Methods"},{"issue":"11","key":"4313_CR51","doi-asserted-by":"publisher","first-page":"e1009442","DOI":"10.1371\/journal.pcbi.1009442","volume":"17","author":"H Mallick","year":"2021","unstructured":"Mallick H, Rahnavard A, McIver LJ, Ma S, Zhang Y, Nguyen LH, et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput Biol. 2021;17(11):e1009442.","journal-title":"PLoS Comput Biol"},{"issue":"6","key":"4313_CR52","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41587-020-0548-6","volume":"38","author":"GM Douglas","year":"2020","unstructured":"Douglas GM, Maffei VJ, Zaneveld JR, Yurgel SN, Brown JR, Taylor CM, et al. PICRUSt2 for prediction of metagenome functions. Nat Biotechnol. 2020;38(6):685\u20138.","journal-title":"Nat Biotechnol"},{"issue":"D1","key":"4313_CR53","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51(D1):D587\u201392.","journal-title":"Nucleic Acids Res"},{"issue":"7808","key":"4313_CR54","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41586-020-2269-x","volume":"581","author":"S Vieira-Silva","year":"2020","unstructured":"Vieira-Silva S, Falony G, Belda E, Nielsen T, Aron-Wisnewsky J, Chakaroun R, et al. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis. Nature. 2020;581(7808):310\u20135.","journal-title":"Nature"},{"issue":"8","key":"4313_CR55","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1136\/gutjnl-2019-320204","volume":"69","author":"RK Weersma","year":"2020","unstructured":"Weersma RK, Zhernakova A, Fu J. Interaction between drugs and the gut Microbiome. Gut. 2020;69(8):1510\u20139.","journal-title":"Gut"},{"issue":"6","key":"4313_CR56","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.chom.2022.05.003","volume":"30","author":"L Guthrie","year":"2022","unstructured":"Guthrie L, Spencer SP, Perelman D, Van Treuren W, Han S, Yu FB, et al. Impact of a 7-day homogeneous diet on interpersonal variation in human gut microbiomes and metabolomes. Cell Host Microbe. 2022;30(6):863\u2013e8744.","journal-title":"Cell Host Microbe"},{"issue":"7346","key":"4313_CR57","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/nature09944","volume":"473","author":"M Arumugam","year":"2011","unstructured":"Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut Microbiome. Nature. 2011;473(7346):174\u201380.","journal-title":"Nature"},{"issue":"12","key":"4313_CR58","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1136\/gutjnl-2021-325753","volume":"71","author":"E Belda","year":"2022","unstructured":"Belda E, Voland L, Tremaroli V, Falony G, Adriouch S, Assmann KE, et al. Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism. Gut. 2022;71(12):2463\u201380.","journal-title":"Gut"},{"issue":"1","key":"4313_CR59","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/COH.0000000000000833","volume":"19","author":"J Capeau","year":"2024","unstructured":"Capeau J, Lagathu C, B\u00e9r\u00e9ziat V. Recent data on the role of antiretroviral therapy in weight gain and obesity in persons living with HIV. Curr Opin HIV AIDS. 2024;19(1):14\u201320.","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"4313_CR60","doi-asserted-by":"publisher","first-page":"54","DOI":"10.24875\/AIDSRev.22000026","volume":"25","author":"E Dupont","year":"2023","unstructured":"Dupont E, Yombi JC. Antiretroviral therapy and weight gain in antiretroviral treatment-experienced HIV patients: A review. AIDS Rev. 2023;25(1):54\u201364.","journal-title":"AIDS Rev"},{"issue":"6","key":"4313_CR61","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11904-024-00708-x","volume":"21","author":"S Savinelli","year":"2024","unstructured":"Savinelli S, Newman E, Mallon PWG. Metabolic complications associated with use of integrase strand transfer inhibitors (InSTI) for the treatment of HIV-1 infection: focus on weight changes, lipids, glucose and bone metabolism. Curr HIV\/AIDS Rep. 2024;21(6):293\u2013308.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"8","key":"4313_CR62","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1093\/cid\/ciab444","volume":"73","author":"KM Erlandson","year":"2021","unstructured":"Erlandson KM, Carter CC, Melbourne K, Brown TT, Cohen C, Das M, et al. Weight change following antiretroviral therapy switch in people with viral suppression: pooled data from randomized clinical trials. Clin Infect Dis Off Publ Infect Dis Soc Am. 2021;73(8):1440\u201351.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"3","key":"4313_CR63","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/cid\/ciy083","volume":"67","author":"DV Glidden","year":"2018","unstructured":"Glidden DV, Mulligan K, McMahan V, Anderson PL, Guanira J, Chariyalertsak S, et al. Metabolic effects of preexposure prophylaxis with coformulated Tenofovir disoproxil fumarate and emtricitabine. Clin Infect Dis Off Publ Infect Dis Soc Am. 2018;67(3):411\u20139.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"9","key":"4313_CR64","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1093\/jac\/dkab158","volume":"76","author":"A Gonz\u00e1lez-Cord\u00f3n","year":"2021","unstructured":"Gonz\u00e1lez-Cord\u00f3n A, Assoumou L, Moyle G, Waters L, Johnson M, Domingo P, et al. Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV. J Antimicrob Chemother. 2021;76(9):2380\u201393.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"4313_CR65","doi-asserted-by":"publisher","first-page":"e0158169","DOI":"10.1371\/journal.pone.0158169","volume":"11","author":"A Castley","year":"2016","unstructured":"Castley A, Williams L, James I, Guelfi G, Berry C, Nolan D. Plasma CXCL10, sCD163 and sCD14 levels have distinct associations with antiretroviral treatment and cardiovascular disease risk factors. PLoS ONE. 2016;11(6):e0158169.","journal-title":"PLoS ONE"},{"issue":"1","key":"4313_CR66","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1161\/ATVBAHA.112.300421","volume":"33","author":"AP Reiner","year":"2013","unstructured":"Reiner AP, Lange EM, Jenny NS, Chaves PHM, Ellis J, Li J, et al. Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adults. Arterioscler Thromb Vasc Biol. 2013;33(1):158\u201364.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"4313_CR67","doi-asserted-by":"publisher","first-page":"030006052211300","DOI":"10.1177\/03000605221130010","volume":"50","author":"YE Kang","year":"2022","unstructured":"Kang YE, Joung KH, Kim JM, Lee JH, Kim HJ, Ku BJ. Serum CD14 concentration is associated with obesity and insulin resistance in non-diabetic individuals. J Int Med Res. 2022;50(10):03000605221130010.","journal-title":"J Int Med Res"},{"key":"4313_CR68","doi-asserted-by":"crossref","unstructured":"Taylor BS, So-Armah K, Tate JP, Marconi VC, Koethe J, Bedimo R et al. HIV and Obesity Comorbidity Increases Interleukin 6 but not Soluble CD14 or D-dimer. J Acquir Immune Defic Syndr. 1999. 2017;75(5):500.","DOI":"10.1097\/QAI.0000000000001444"},{"issue":"5","key":"4313_CR69","doi-asserted-by":"publisher","first-page":"100913","DOI":"10.1016\/j.jpha.2023.12.003","volume":"14","author":"Y Han","year":"2024","unstructured":"Han Y, Sun Q, Chen W, Gao Y, Ye J, Chen Y, et al. New advances of adiponectin in regulating obesity and related metabolic syndromes. J Pharm Anal. 2024;14(5):100913.","journal-title":"J Pharm Anal"},{"issue":"2","key":"4313_CR70","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1530\/JME-14-0089","volume":"53","author":"K Fjeldborg","year":"2014","unstructured":"Fjeldborg K, M\u00f8ller HJ, Richelsen B, Pedersen SB. Regulation of CD163 mRNA and soluble CD163 protein in human adipose tissue in vitro. J Mol Endocrinol. 2014;53(2):227\u201335.","journal-title":"J Mol Endocrinol"},{"issue":"11","key":"4313_CR71","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s40618-019-01052-3","volume":"42","author":"I Barchetta","year":"2019","unstructured":"Barchetta I, Cimini FA, Ciccarelli G, Baroni MG, Cavallo MG. Sick fat: the good and the bad of old and new Circulating markers of adipose tissue inflammation. J Endocrinol Invest. 2019;42(11):1257\u201372.","journal-title":"J Endocrinol Invest"},{"issue":"16","key":"4313_CR72","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1097\/QAD.0000000000000817","volume":"29","author":"LJ Conley","year":"2015","unstructured":"Conley LJ, Bush TJ, Rupert AW, Sereti I, Patel P, Brooks JT, et al. Obesity is associated with greater inflammation and monocyte activation among HIV-infected adults receiving antiretroviral therapy. AIDS Lond Engl. 2015;29(16):2201\u20137.","journal-title":"AIDS Lond Engl"},{"issue":"4","key":"4313_CR73","doi-asserted-by":"publisher","first-page":"e0214735","DOI":"10.1371\/journal.pone.0214735","volume":"14","author":"V Subramanya","year":"2019","unstructured":"Subramanya V, McKay HS, Brusca RM, Palella FJ, Kingsley LA, Witt MD, et al. Inflammatory biomarkers and subclinical carotid atherosclerosis in HIV-infected and HIV-uninfected men in the multicenter AIDS cohort study. PLoS ONE. 2019;14(4):e0214735.","journal-title":"PLoS ONE"},{"issue":"11","key":"4313_CR74","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1093\/cid\/ciz561","volume":"70","author":"S Dirajlal-Fargo","year":"2020","unstructured":"Dirajlal-Fargo S, El-Kamari V, Weiner L, Shan L, Sattar A, Kulkarni M, et al. Altered intestinal permeability and fungal translocation in Ugandan children with human immunodeficiency virus. Clin Infect Dis Off Publ Infect Dis Soc Am. 2020;70(11):2413\u201322.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"8","key":"4313_CR75","doi-asserted-by":"publisher","first-page":"ofad328","DOI":"10.1093\/ofid\/ofad328","volume":"10","author":"ML Freeman","year":"2023","unstructured":"Freeman ML, Hossain MB, Burrowes SAB, Jeudy J, Bui R, Moisi D, et al. Association of soluble markers of inflammation with Peri-coronary artery inflammation in people with and without HIV infection and without cardiovascular disease. Open Forum Infect Dis. 2023;10(8):ofad328.","journal-title":"Open Forum Infect Dis"},{"key":"4313_CR76","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ebiom.2016.01.032","volume":"5","author":"M Noguera-Julian","year":"2016","unstructured":"Noguera-Julian M, Rocafort M, Guill\u00e9n Y, Rivera J, Casadell\u00e0 M, Nowak P, et al. Gut microbiota linked to sexual preference and HIV infection. EBioMedicine. 2016;5:135\u201346.","journal-title":"EBioMedicine"},{"issue":"11","key":"4313_CR77","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41579-024-01068-4","volume":"22","author":"FC Ross","year":"2024","unstructured":"Ross FC, Patangia D, Grimaud G, Lavelle A, Dempsey EM, Ross RP, et al. The interplay between diet and the gut microbiome: implications for health and disease. Nat Rev Microbiol. 2024;22(11):671\u201386.","journal-title":"Nat Rev Microbiol"},{"key":"4313_CR78","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1146\/annurev-physiol-031522-092054","volume":"85","author":"BK Perler","year":"2023","unstructured":"Perler BK, Friedman ES, Wu GD. The role of the gut microbiota in the relationship between diet and human health. Annu Rev Physiol. 2023;85:449\u201368.","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"4313_CR79","first-page":"61","volume":"1540","author":"MI McBurney","year":"2024","unstructured":"McBurney MI, Cho CE. Understanding the role of the human gut Microbiome in overweight and obesity. Ann N Y Acad Sci. 2024;1540(1):61\u201388.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"4313_CR80","doi-asserted-by":"publisher","first-page":"e13550","DOI":"10.1111\/obr.13550","volume":"24","author":"LN Anderson","year":"2023","unstructured":"Anderson LN, Yoshida-Montezuma Y, Dewart N, Jalil E, Khattar J, De Rubeis V, et al. Obesity and weight change during the COVID-19 pandemic in children and adults: A systematic review and meta-analysis. Obes Rev Off J Int Assoc Study Obes. 2023;24(5):e13550.","journal-title":"Obes Rev Off J Int Assoc Study Obes"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04313-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04313-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04313-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:24:59Z","timestamp":1756898699000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-04313-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4313"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04313-9","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics, Research and Safety Committees of the Instituto Nacional de Enfermedades Respiratorias Ismael Cos\u00edo Villegas (INER) under approval number C71-18 and C15-16. All participants were informed of the study objectives and signed an informed consent. All participants were 18 years or older. The study was conducted according to the Declaration of Helsinki of 1964 and later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"569"}}